ASAM Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use

June 19th, 2015

ASAM (6/2/15): ASAM announces the release of its National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use (Practice Guideline). The Practice Guideline will assist clinicians prescribing pharmacotherapies to patients with addiction related to opioid use. It addresses knowledge gaps about the benefits of treatment medications and their role in recovery, while guiding evidence-based coverage standards by payers.

ASAM worked with Treatment Research Institute (TRI) to develop the Practice Guideline using the RAND/UCLA Appropriateness Method (RAM), a consensus process that combines scientific evidence with clinical knowledge. A Guideline Committee, made up of experts from multiple disciplines, including addiction medicine, psychiatry, obstetrics/gynecology and internal medicine, participated in the consensus process and helped write the guideline. Dr. Kyle Kampman chaired the Guideline Committee and served as TRI’s Principal Investigator. “The Practice Guideline is the most current document of its kind combining review of existing guidelines, current literature and a systematic process for developing practice recommendations.”

Read More

Posted in Content


A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.